Clinical Management of HBV | Room 716

Saturday, June 16, 2018
4:15 PM to 6:00 PM

Chair: Scott Fung & Adrian DiBisceglie

Invited Presentations:

4:15pm
Long-term benefits provided by current generation of nucleoside analogues
Jin Lin Hou, Nanfang Hospital, Southern Medical University, Guangdong Sheng

4:40pm
How to handle antiviral treatment in immuno-suppressed patients
Jordan Feld, Toronto Centre for Liver Disease, Toronto

5:05pm
Management of HBV in pregnancy
Carla Coffin, University Of Calgary, Calgary

Oral Abstracts:

5:30pm
Safety and efficacy at 1 year after switching from tenofovir disoproxil fumurate to tenofovir alafenamide in chronic HBV patients with risk factors for TDF use
Harry Janssen, Toronto Centre for Liver Disease, Toronto

5:45pm
Low serum HBsAg and HBV DNA levels identify strongest responders of pegylated interferon addition to entecavir in HBeAg positive chronic hepatitis B
Seng Liem, University Health Network, Toronto

Return to Schedule